In the news

  • Article title

    Cancer Diagnostics group VolitionRX looks ahead to 2018

  • Article title

    VolitionRx eyeing 'breakthrough' 2018 as it completes Copenhagen trial

  • Article title

    The blood trail to diagnose colorectal cancer

  • Article title

    CEO, Cameron Reynolds is interviewed by London South East

  • Article title

    Big EU trials on deck

  • Article title

    Volition expects to market ‘revolutionary’ colorectal cancer blood test Q3 2018

  • Article title

    VolitionRx surges after unveiling plans to conduct two massive clinical studies

  • Article title

    Volition’s Scott Powell, Interviewed at Qualified Capital Fall Investor Event 2017

  • Article title

    Paula Middlehurst from Stock Tube Interviews CEO, Cameron Reynolds on Q2 2017

  • Article title

    KVUE ABC interviews Chief Medical Officer of Volition and Chief Executive Officer of Volition America Inc, Dr. Jason Terrell

arrow-downarrow-leftarrow-rightarrowchevron-downcircle-link--redcircle-linkcloseplayplus